AI could review data sets to assist clinical scientists ...
Makary pointed to three bottlenecks: hospital contracting; ethical reviews and approvals; and the Investigational New Drug ...
In response to Marty Makary warning the US may lose the early‑stage drug development lead to China, Brian Scanlan says speed, ...
Mayo Clinic, for its part, described the collaboration as its first strategic partnership of this scale with a global ...
The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...
Using AI to assemble real-world COPD data can help to identify specific clinical traits faster and with greater accuracy than traditional data sources This collaboration supports Tessel's drug ...
Explore the role of BD&L in R&D decision-making. Understand its impact on funding and market intelligence for scientists.
Announcement reinforces SGS’s position as one of the few European CROs offering end-to-end human ADME programs This ...
In this forward-looking whitepaper, Blue Mountain explores how agentic AI —autonomous, context-aware AI agents—could ...
BASEL, Switzerland--(BUSINESS WIRE)--Indivi and Clouds of Care, two independent TechBio companies, today announced a strategic partnership to advance the use of precision medicine tools in early-phase ...
This episode of the Pharmaron DMPK Insights Podcast Series sees Simon Taylor (Vice President of Drug Discovery at Pharmaron) and Dr. Emile Chen (former Director of Modeling and Translational Biology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results